Notice of Results

RNS Number : 6465P
Instem plc
04 September 2017
 

 

Instem plc 

 

Notice of Results 

 

Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, will announce half year results for the six months ended 30 June 2017 on Tuesday 26th September 2017.

 

Management will be hosting a presentation for analysts on the day of the results at 9.30am. Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.

 

 

For further information, please contact:

 

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO

Nigel Goldsmith, CFO

 

 

N+1 Singer (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Richard Lindley

Nick Owen

 

 

Walbrook Financial PR

+44 (0) 20 7933 8000

Paul Cornelius

Helen Cresswell

Sam Allen

instem@walbrookpr.com

 

About Instem 

Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India. 

To learn more about Instem solutions and its mission, please visit www.instem.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORDMGGLKMNGNZM

Companies

Instem (INS)
UK 100

Latest directors dealings